UNI-EN 135:Notifiation for insiders' transations
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 135 | / | 2017 | |||||||
| Date of issue: | 2017-12-28 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notifiation for insiders' transations | |||||||||||
| Official market - legal basis | |||||||||||
| art. 19. 3 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| NOTIFICATION OF INSIDERS’ TRANSACTIONS SOPHARMA AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that he, executed the following transactions related to shares in the Company: Date of the transaction Operation Number of shares Unit price (BGN) 21.12.2017 Buy 1 609 4.2700 21.12.2017 Buy 3 391 4.2700 21.12.2017 Buy 121 4.2700 21.12.2017 Buy 199 4.2700 21.12.2017 Buy 1 000 4.2700 21.12.2017 Buy 500 4.2700 21.12.2017 Buy 130 4.2700 22.12.2017 Buy 1 628 4.2700 22.12.2017 Buy 372 4.2700 22.12.2017 Buy 950 4.2830 22.12.2017 Buy 100 4.2830 22.12.2017 Buy 1 490 4.2830 22.12.2017 Buy 510 4.2830 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report re insiders transactions -135-Donev.doc Current report re insiders transactions -135-Donev.doc | Notifiation for insiders' transations | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2017-12-28 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
